|
|
Volumn 96, Issue 21, 2004, Pages 1570-1572
|
|
Researchers optimistic about targeted drugs for pancreatic cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
CAMPOSTAR;
CETUXIMAB;
DOCETAXEL;
DOXORUBICIN;
ERLOTINIB;
FLUOROURACIL;
FOLINIC ACID;
GEMCITABINE;
IMATINIB;
IRINOTECAN;
MATRIX METALLOPROTEINASE INHIBITOR;
SUNITINIB;
UNCLASSIFIED DRUG;
VATALANIB;
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
MONOCLONAL ANTIBODY;
NEW DRUG;
PIPERAZINE DERIVATIVE;
PLATELET DERIVED GROWTH FACTOR RECEPTOR;
PYRIMIDINE DERIVATIVE;
VASCULOTROPIN RECEPTOR;
ANTINEOPLASTIC ACTIVITY;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CELL MIGRATION;
CLINICAL TRIAL;
DRUG TARGETING;
ENDOTHELIUM CELL;
EXPERIMENTAL DESIGN;
FATIGUE;
FIBROBLAST;
GAMMA KNIFE RADIOSURGERY;
HUMAN;
IMMUNOCOMPETENT CELL;
INFLAMMATORY CELL;
MEDICAL SOCIETY;
NONHUMAN;
NOTE;
PANCREAS CANCER;
PRIORITY JOURNAL;
ADENOCARCINOMA;
ARTICLE;
DRUG ANTAGONISM;
METABOLISM;
METHODOLOGY;
MORTALITY;
PANCREAS TUMOR;
PATHOLOGY;
SURVIVAL;
ADENOCARCINOMA;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
DRUGS, INVESTIGATIONAL;
HUMANS;
PANCREATIC NEOPLASMS;
PIPERAZINES;
PYRIMIDINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RECEPTORS, PLATELET-DERIVED GROWTH FACTOR;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
RESEARCH DESIGN;
SURVIVAL ANALYSIS;
|
|
EID: 7944226035
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/96.21.1570 Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|